FDA Approves VONVENDI for Broader VWD Treatment in Adul...

On September 5, 2025, Takeda announced that the U.S. Food and Drug Administration (FDA) approved the supplemental Biologics License Application (sBLA) for VONVENDI® [von Willebrand factor (Recombinan...

Published: 09 Sep 2025

Written by Sneha Nangare